NCT04448314View on ClinicalTrials.gov

Study to Evaluate the Usability of PointCheck

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

February 11, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
NeoplasmsChemotherapy-induced Neutropenia
Interventions
DIAGNOSTIC_TEST

PointCheck

This is a usability study on PointCheck, a new technology to detect chemotherapy-induced neutropenia

Trial Locations (3)

28041

Breast Unit. Oncology Department. 12 Octubre Hospital, Madrid

28049

Hospital Universitario 12 de Octubre, Madrid

08028

Hospital Universitari Dexeus. Grupo Quirónsalud, Barcelona

All Listed Sponsors
lead

Leuko Labs, Inc.

INDUSTRY

NCT04448314 - Study to Evaluate the Usability of PointCheck | Biotech Hunter | Biotech Hunter